Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) rose 0.6% during trading on Monday . The stock traded as high as $30.39 and last traded at $30.05. Approximately 95,479 shares traded hands during trading, a decline of 23% from the average daily volume of 124,734 shares. The stock had previously closed at $29.87.
Innovator IBD 50 ETF Price Performance
The stock has a fifty day simple moving average of $30.14 and a two-hundred day simple moving average of $27.91. The firm has a market capitalization of $97.66 million, a P/E ratio of 18.67 and a beta of 1.50.
Institutional Trading of Innovator IBD 50 ETF
Several hedge funds have recently modified their holdings of the stock. Jane Street Group LLC grew its holdings in Innovator IBD 50 ETF by 51.5% in the third quarter. Jane Street Group LLC now owns 49,781 shares of the company’s stock worth $1,339,000 after purchasing an additional 16,912 shares during the period. IHT Wealth Management LLC boosted its position in shares of Innovator IBD 50 ETF by 70.8% during the 3rd quarter. IHT Wealth Management LLC now owns 66,688 shares of the company’s stock worth $1,784,000 after purchasing an additional 27,637 shares in the last quarter. Cowa LLC boosted its position in shares of Innovator IBD 50 ETF by 158.4% during the 3rd quarter. Cowa LLC now owns 24,763 shares of the company’s stock worth $666,000 after purchasing an additional 15,180 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in shares of Innovator IBD 50 ETF by 2,590.0% in the 3rd quarter. International Assets Investment Management LLC now owns 26,900 shares of the company’s stock valued at $724,000 after buying an additional 25,900 shares during the period.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Articles
- Five stocks we like better than Innovator IBD 50 ETF
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What Is WallStreetBets and What Stocks Are They Targeting?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How to Calculate Options Profits
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.